BDSI实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (23 Mar 2022 @ 04:00):

Stats
今日成交量	2.11M
平均成交量	3.35M
市值	577.05M
EPS	$0.650 ( Q4 \| 2022-03-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	6.82 (Sector) 42.63 (Industry) 30.78
ATR14	$0.0920 (1.65%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2022-03-22	Watson W. Mark	Sell	54 740	Stock Options (right to buy)
2022-03-22	Watson W. Mark	Sell	90 663	Common Stock
2022-03-22	Vollins James	Sell	91 401	Restricted Stock Units
2022-03-22	Vollins James	Sell	29 826	Stock Options (right to buy)
2022-03-22	Vollins James	Sell	43 334	Stock Options (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 5 634 641 \| Sell: 24 333 206

音量相关性

長: 0.22 (neutral)

短: 0.00 (neutral)

Signal:(83.092) Neutral

BioDelivery Sciences 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BioDelivery Sciences 相关性 - 货币/商品

-0.45
( neutral )

-0.55
( weak negative )

-0.80
( strong negative )

0.31
( neutral )

0.75
( moderate )

-0.23
( neutral )

BioDelivery Sciences 财务报表

Annual	2021
营收:	$166.70M
毛利润:	$143.33M (85.98 %)
EPS:	$0.850

FY	2021
营收:	$166.70M
毛利润:	$143.33M (85.98 %)
EPS:	$0.850

FY	2020
营收:	$156.47M
毛利润:	$131.81M (84.24 %)
EPS:	$0.260

FY	2019
营收:	$111.39M
毛利润:	$89.80M (80.62 %)
EPS:	$-0.180

Financial Reports:

No articles found.

BioDelivery Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BioDelivery Sciences

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.